Prime Minister YS Jagan Mohan Reddy’s proposal that Bharat Biotech’s transfer of Covaxin manufacturing technology to companies capable of replicating the virus strain in order to quickly boost vaccine production be hailed as a good idea among political leaders of the country has become more topical.
The recent letter to Prime Minister Narendra Modi proposing technology transfer from Jagan Mohan Reddy demonstrated his commitment to increasing the capacity to manufacture vaccines at the desired pace by engaging as many competent actors as possible to meet the rapidly growing demand said an official publication.
The compulsory licensing of Covaxin production was stated to have been initiated by Mr Jagan Mohan Reddy and it was established in a very short time by 12 leaders from various parties, mainly including Delhi Chief Minister Arvind Kejriwal.
More importantly, the idea was endorsed by NITI Aayog member VK Paul.
Now the central government had decided to let other companies manufacture the urgently needed vaccine.
The Chief Minister of Andhra Pradesh also noted that since Covaxin was developed by Bharath Biotech in collaboration with the Indian Council for Medical Research and the National Institute of Virology in PPP mode, IPR problems would arise when sharing the technology with other pharmaceutical companies .